Compare BNBX & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNBX | NXTS |
|---|---|---|
| Founded | 1983 | 2009 |
| Country | United States | Israel |
| Employees | 26 | 9 |
| Industry | Other Consumer Services | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.4M |
| IPO Year | N/A | N/A |
| Metric | BNBX | NXTS |
|---|---|---|
| Price | $0.47 | $4.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 303.8K | 19.6K |
| Earning Date | 05-14-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $253.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $0.55 |
| 52 Week High | $6.17 | $6.21 |
| Indicator | BNBX | NXTS |
|---|---|---|
| Relative Strength Index (RSI) | 34.28 | 53.12 |
| Support Level | $0.45 | $3.92 |
| Resistance Level | $0.85 | $5.31 |
| Average True Range (ATR) | 0.03 | 0.62 |
| MACD | 0.00 | -0.17 |
| Stochastic Oscillator | 17.37 | 20.98 |
BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.